Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.
Read the full article » | Posted 05/09/2017
- AWAK PD Attracts Funding Posted 01/09/2020
- PD to Go, Please Posted 12/10/2019
- Portable, Wearable Dialysis—from Russia With Love Posted 12/10/2019
- Fresenius-licensed Endexo Smart Polymer Gets FDA Breakthrough Status to Prevent Clots Posted 11/16/2019
- Diality is Moving Forward with Portable Home HD Posted 11/16/2019